DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Danes - 1 Lars Skovgaard Andersen - 1 Lars Christensen - 1 Wegovy - 1 Mads Krogsgaard Thomsen - 1 " Thomsen - 1 Moller - 1 Thomsen - 1
Top related locs:
COPENHAGEN Denmark Stockholm Copenhagen Danish Novo Europe North America
Top related orgs:
Novo Nordisk - 1 Novo Nordisk Foundation - 1 Danske Bank - 1 Copenhagen Business School - 1 Novo - 1 Foundation - 1 Novo Holdings - 1 Carlsberg - 1

Search resuls for: "Lars Skovgaard Andersen"


2 mentions found


☆ Novo Nordisk's Wegovy bonanza looms large in Denmark
  + stars: | 2023-10-05 | by ( Maggie Fick | ) www.reuters.com   time to read: +6 min
COPENHAGEN, Oct 5 (Reuters) - The whirlwind success of weight-loss treatment Wegovy is providing a bonanza not just for its developer, Novo Nordisk (NOVOb.CO), but also for its home country of Denmark. Interviews with Danish economists, analysts, and executives at the Novo Nordisk Foundation which controls Novo highlight the benefits to the economy from jobs to private wealth - but also the potential pitfalls of relying on a single, outsized company. Record profits for Novo are projected to generate returns for the Foundation of more than $12 billion in coming years. Novo Nordisk added 3,500 jobs in Denmark in 2022, bringing the total in the country to 21,000 employees, out of 59,000 worldwide, a company spokesperson said. Before Wegovy, "we used to be kind of, 'Isn't Denmark the place where Stockholm is the capital?'"
Persons: Danes, Lars Skovgaard Andersen, Lars Christensen, Wegovy, Mads Krogsgaard Thomsen, " Thomsen, Moller, Thomsen, Melinda Gates, Rasmus Kristian Feldthusen, Maggie Fick, Jacob Gronholt, Alexander Smith, Josephine Mason, Michele Gershberg, Catherine Evans Organizations: Novo Nordisk, Novo Nordisk Foundation, Danske Bank, Copenhagen Business School, Novo, Foundation, Reuters, Novo Holdings, Carlsberg, Maersk, U.S, Melinda Gates Foundation, UK's Wellcome Trust, Wegovy, University of Copenhagen, Nokia, Pedersen, Thomson Locations: COPENHAGEN, Denmark, Stockholm, Copenhagen, Danish, Novo, Europe, North America, Asia, OUTGROWING DENMARK, Finland
☆ Investors see big Novo Nordisk stock boost if obesity drug shows heart benefit
  + stars: | 2023-05-03 | by ( Maggie Fick | ) www.reuters.com   time to read: +5 min
Demand for the Danish company's weight-loss treatment Wegovy is soaring in the United States, leading it to significantly raise its full-year profit and sales expectations last month. "But most insurance companies (...) may need to see that data, to definitively see the correlation between weight loss and improved outcomes." Less than 15% could put downward pressure on the stock while around 10% would be a major disappointment, some of the investors and analysts said. Booming demand and production issues have caused shortages of Wegovy though, forcing Novo to delay launching the weekly injection in most of Europe. Even with the medical benefit, investors say the company faces a challenge convincing Europe's cost-conscious health authorities to pay for the drug.
0 next >>
Total: 2